POLY MEDICURE Financial Statement Analysis
|
||
|
The Revenues of POLY MEDICURE have increased by 23.36% YoY .
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 24.15 % YoY. |
||
POLY MEDICURE Last 5 Annual Financial Results
[BOM: 531768|NSE : POLYMED]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,376 Cr | ₹1,115 Cr | ₹923 Cr | ₹786 Cr | ₹687 Cr |
| Expenses | ₹1,016 Cr | ₹848 Cr | ₹708 Cr | ₹570 Cr | ₹521 Cr |
| Operating Profit (Excl OI) | ₹360 Cr | ₹267 Cr | ₹215 Cr | ₹216 Cr | ₹166 Cr |
| Other Income | ₹59 Cr | ₹36 Cr | ₹38 Cr | ₹18 Cr | ₹18 Cr |
| Interest | ₹14 Cr | ₹11 Cr | ₹6.16 Cr | ₹11 Cr | ₹20 Cr |
| Depreciation | ₹63 Cr | ₹57 Cr | ₹54 Cr | ₹48 Cr | ₹41 Cr |
| Profit Before Tax | ₹344 Cr | ₹237 Cr | ₹195 Cr | ₹180 Cr | ₹126 Cr |
| Profit After Tax | ₹258 Cr | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr |
| Consolidated Net Profit | ₹258 Cr | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr |
| Earnings Per Share (Rs) | ₹33.41 | ₹26.91 | ₹18.69 | ₹15.28 | ₹14.17 |
| PAT Margin (%) | 20.19 | 18.70 | 16.01 | 15.80 | 17.19 |
| ROE(%) | 16.01 | 19.09 | 15.42 | 14.29 | 19.42 |
| ROCE(%) | 20.37 | 23.63 | 19.10 | 17.42 | 21.96 |
| Total Debt/Equity(x) | 0.06 | 0.12 | 0.12 | 0.12 | 0.14 |
Key Financials |
||
| Market Cap | : | ₹ 16,971.8 Cr |
| Revenue (TTM) | : | ₹ 1,875.3 Cr |
| Net Profit(TTM) | : | ₹ 315.0 Cr |
| EPS (TTM) | : | ₹ 31.1 |
| P/E (TTM) | : | 53.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| POLY MEDICURE | 10.4% | 7.9% | -28.8% |
| LENSKART SOLUTIONS | 2.7% | 3.5% | NA |
| 3B BLACKBIO DX | -5.1% | -0.2% | -22.5% |
| LAXMI DENTAL | -0.9% | 8.7% | -47.7% |
| PREVEST DENPRO | -0.9% | -0.1% | -17.8% |
| NURECA | 0.4% | -12% | -13.6% |
POLY MEDICURE Revenues
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 23.36 % |
| 5 Yr CAGR | 18.95 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,376 Cr | 23.36 | |
| Mar2024 | ₹1,115 Cr | 20.82 | |
| Mar2023 | ₹923 Cr | 17.37 | |
| Mar2022 | ₹786 Cr | 14.44 | |
| Mar2021 | ₹687 Cr | - | |
POLY MEDICURE Operating Profit
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 34.63 % |
| 5 Yr CAGR | 21.33 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹360 Cr | 34.63 | |
| Mar2024 | ₹267 Cr | 24.37 | |
| Mar2023 | ₹215 Cr | -0.68 | |
| Mar2022 | ₹216 Cr | 30.32 | |
| Mar2021 | ₹166 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 9.13 % |
| 5 Yr CAGR | 2.01 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 26.17% | 9.13 | |
| Mar2024 | 23.98% | 2.96 | |
| Mar2023 | 23.29% | -15.40 | |
| Mar2022 | 27.53% | 13.90 | |
| Mar2021 | 24.17% | - | |
POLY MEDICURE Profit After Tax
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 44.05 % |
| 5 Yr CAGR | 28.11 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹258 Cr | 44.05 | |
| Mar2024 | ₹179 Cr | 22.37 | |
| Mar2023 | ₹147 Cr | 7.82 | |
| Mar2022 | ₹136 Cr | 41.72 | |
| Mar2021 | ₹96 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 7.97 % |
| 5 Yr CAGR | 4.10 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 20.19 % | 7.97 | |
| Mar2024 | 18.7 % | 16.80 | |
| Mar2023 | 16.01 % | 1.33 | |
| Mar2022 | 15.8 % | -8.09 | |
| Mar2021 | 17.19 % | - | |
POLY MEDICURE Earnings Per Share (EPS)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | 24.15 % |
| 5 Yr CAGR | 23.92 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 | 24.15 | |
| Mar2024 | ₹27 | 43.98 | |
| Mar2023 | ₹19 | 22.32 | |
| Mar2022 | ₹15 | 7.83 | |
| Mar2021 | ₹14 | - | |
POLY MEDICURE Return on Capital Employed (ROCE)
[BOM: 531768|NSE : POLYMED]
| Y-o-Y | -13.80 % |
| 5 Yr CAGR | -1.86 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 20.37% | -13.80 | |
| Mar2024 | 23.63% | 23.72 | |
| Mar2023 | 19.1% | 9.64 | |
| Mar2022 | 17.42% | -20.67 | |
| Mar2021 | 21.96% | - | |
POLY MEDICURE Share Price vs Sensex
| Current Share Price | : | ₹1,673.8 |
| Current MarketCap | : | ₹ 16,971.8 Cr |
| Updated EOD on | : | Jun 22,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| POLY MEDICURE | 10.4% |
7.9% |
-28.8% |
| SENSEX | 1.1% |
2.4% |
-5% |
POLY MEDICURE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 250 SMALLCAP INDEX | 3% | 6.7% | 3.4% |
| BSE 400 MIDSMALLCAP INDEX | 2.5% | 4.3% | 4.9% |
| BSE HEALTHCARE | 2.3% | 1.2% | 9.6% |
| BSE 1000 | 1.8% | 3.4% | 1.5% |
| BSE 500 | 1.6% | 3% | 1.1% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP250 QUALITY 50 | 3.4% | 3.7% | -7.1% |
| NIFTY SMALLCAP 500 | 3.3% | 7.8% | NA |
| NIFTY SMALLCAP 250 | 3.2% | 7% | 3.7% |
| NIFTY SMALLCAP250 MOMENTUM QUALITY 100 INDEX | 3% | 4.2% | -0.9% |
| NIFTY MIDSMALLCAP400 50:50 | 2.7% | 4.9% | NA |
You may also like the below Video Courses
FAQ about POLY MEDICURE Financials
How the annual revenues of POLY MEDICURE have changed ?
The Revenues of POLY MEDICURE have increased by 23.36% YoY .
How the Earnings per Share (EPS) of POLY MEDICURE have changed?
The Earnings Per Share (EPS) of POLY MEDICURE has increased by 24.15 % YoY .
Check out Intrinsic Value of Peers of POLY MEDICURE
|
Intrinsic Value of LENSKART SOLUTIONS LTD Intrinsic Value of POLY MEDICURE LTD Intrinsic Value of 3B BLACKBIO DX LTD Intrinsic Value of LAXMI DENTAL LTD Intrinsic Value of PREVEST DENPRO LTD |
Compare Stock Analytics of Peers of POLY MEDICURE
LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD
LAXMI DENTAL LTD vs PREVEST DENPRO LTD vs
LENSKART SOLUTIONS LTD vs POLY MEDICURE LTD vs 3B BLACKBIO DX LTD
LAXMI DENTAL LTD vs PREVEST DENPRO LTD vs
